Hematology and Oncology

Clinical Translational Research

Investigators with Penn Hematology/Oncology are focused on translating laboratory work into novel therapies and practice-changing discoveries.

Discover our findings

Welcome From Lynn M. Schuchter, MD – Chief

Penn Medicine's Division of Hematology/Oncology is one of the largest hematology/oncology groups in the country. We are recognized nationally and internationally for our excellence in patient care, research and training. Our physicians and nurses care for patients with all types of cancer and benign blood-related disorders, from the most common to the most complex, seeing more than 175,000 outpatient visits annually.

Read the full Message

Lynn M. Schuchter, MD

Chief, Division of Hematology Oncology
Director, Tara Miller Melanoma Center at the Abramson Cancer Center at the University of Pennsylvania
C. Willard Robinson Professor of Hematology-Oncology

Clinical Care Programs

Extraordinary patient care is the number one priority of Penn's Division of Hematology and Oncology.

Our clinical programs
Fellowship Program

The hematology/oncology fellowship program at Penn is designed to provide our trainees with the tools they need to pursue lifelong careers characterized by excellence, innovation and commitment.

Read more
Diversity and Inclusion

The Hematology/Oncology Division is committed to enhancing diversity and inclusion throughout our division.

Learn more

In This Section

About Us

Penn Medicine's Division of Hematology and Oncology is an internationally recognized leader in patient care and research.

Faculty

Meet the faculty of the Division of Hematology and Oncology.

Clinical Care

Penn's Division of Hematology and Oncology offers a comprehensive list of services.

Education and Training

Penn’s Division of Hematology and Oncology provides a 3-year Hematology/Oncology Fellowship.

Penn Hematology/Oncology researchers are making important discoveries in diverse fields, ranging from the most fundamental cellular investigations, to the most leading edge translational and clinical research.